Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Ware

Showing results (171-180 of 267) with videos related to

Pageof 27
Sort By:
Environmental and Molecular Mutagenesis|February 26, 2023
Lack of hydroxyurea-associated mutagenesis in pediatric sickle cell disease patientsDorothea K Torous, Svetlana Avlasevich, Jeffrey C Bemis, et al.
The Lancet. Haematology|March 4, 2023
Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trialEmmanuela E Ambrose, Teresa S Latham, Primrose Songoro, et al.
Blood|January 3, 2024
Hydroxyurea reduces infections in children with sickle cell anemia in UgandaRuth Namazzi, Caitlin Bond, Andrea L Conroy, et al.
JMIR Research Protocols|June 25, 2016
Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical TrialJuliana N Anyanwu, Olatundun Williams, Casey L Sautter, et al.
British Journal of Haematology|February 25, 2012
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemiaJonathan M Flanagan, Shirley Steward, Thad A Howard, et al.
Blood|October 21, 2017
Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemiaRobert O Opoka, Christopher M Ndugwa, Teresa S Latham, et al.
American Journal of Hematology|September 16, 2017
A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapyJeremie H Estepp, Matthew P Smeltzer, Guolian Kang, et al.
American Journal of Hematology|February 23, 2026
Artificial Intelligence-Based Analysis of Central Nervous System Vasculopathy in Pediatric Sickle Cell AnemiaMeredith E Fay, Raghav Tandon, Teresa Latham, et al.
Pediatric Blood & Cancer|December 23, 2025
Prolonged, Unintentional Overdose of Hydroxyurea in a Child With Sickle Cell AnemiaMarina K Girgis, Tyler R Lopachin, T Christy Hallett, et al.
Blood Advances|May 12, 2023
Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemiaAngela Rankine-Mullings, Russell Keenan, Subarna Chakravorty, et al.
Pageof 27

Showing results (171-180 of 267) with videos related to

Sort By:
Pageof 27
Environmental and Molecular Mutagenesis|February 26, 2023
Lack of hydroxyurea-associated mutagenesis in pediatric sickle cell disease patientsDorothea K Torous, Svetlana Avlasevich, Jeffrey C Bemis, et al.
The Lancet. Haematology|March 4, 2023
Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trialEmmanuela E Ambrose, Teresa S Latham, Primrose Songoro, et al.
Blood|January 3, 2024
Hydroxyurea reduces infections in children with sickle cell anemia in UgandaRuth Namazzi, Caitlin Bond, Andrea L Conroy, et al.
JMIR Research Protocols|June 25, 2016
Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical TrialJuliana N Anyanwu, Olatundun Williams, Casey L Sautter, et al.
British Journal of Haematology|February 25, 2012
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemiaJonathan M Flanagan, Shirley Steward, Thad A Howard, et al.
Blood|October 21, 2017
Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemiaRobert O Opoka, Christopher M Ndugwa, Teresa S Latham, et al.
American Journal of Hematology|September 16, 2017
A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapyJeremie H Estepp, Matthew P Smeltzer, Guolian Kang, et al.
American Journal of Hematology|February 23, 2026
Artificial Intelligence-Based Analysis of Central Nervous System Vasculopathy in Pediatric Sickle Cell AnemiaMeredith E Fay, Raghav Tandon, Teresa Latham, et al.
Pediatric Blood & Cancer|December 23, 2025
Prolonged, Unintentional Overdose of Hydroxyurea in a Child With Sickle Cell AnemiaMarina K Girgis, Tyler R Lopachin, T Christy Hallett, et al.
Blood Advances|May 12, 2023
Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemiaAngela Rankine-Mullings, Russell Keenan, Subarna Chakravorty, et al.
Pageof 27